tetracaine has been researched along with Cancer of Pituitary in 1 studies
Tetracaine: A potent local anesthetic of the ester type used for surface and spinal anesthesia.
tetracaine : A benzoate ester in which 4-N-butylbenzoic acid and 2-(dimethylamino)ethanol have combined to form the ester bond; a local ester anaesthetic (ester caine) used for surface and spinal anaesthesia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thaw, C | 1 |
| Wittlin, SD | 1 |
| Gershengorn, MC | 1 |
1 other study available for tetracaine and Cancer of Pituitary
| Article | Year |
|---|---|
Tetracaine, propranolol and trifluoperazine inhibit thyrotropin releasing hormone-induced prolactin secretion from GH3 cells by displacing membrane calcium: further evidence that TRH acts to mobilize cellular calcium.
Topics: Animals; Calcium; Cell Line; Cell Membrane; Pituitary Neoplasms; Prolactin; Propranolol; Rats; Tetra | 1982 |